8 results
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockers⠀
Class II
Vaughan Williams Classification ... - Summary Table ... are beta blockers ... #Medications #Classification ... #Summary #Table
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Beta Blockers - ... Pharmacology Comparison ... EricsMedicalLectures/ #Beta ... #Comparison #Table ... #Receptors #cardiology
Non-lschemic Causes of Cardiogenic Shock:

Beta-Blockers, Calcium Channel Blockers, Digoxin 

Myocarditis 

Cardiomyopathies (sarcoidosis, amyloidosis, Takatsubo, 
hemochromatosis) 

Valvular
Cardiogenic Shock: Beta-Blockers ... Calcium Channel Blockers ... Fibrillation AV nodal dysfunction ... , Sinus nodal dysfunction ... Differential #Diagnosis #Cardiology
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
Vaughan Williams Classification ... 2 - Beta Blockers ... alpha & beta adrenergic ... inotropy) ACCP Cardiology ... #cardiology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Vaughan Williams Classification ... 2 - Beta Blockers ... alpha & beta adrenergic ... inotropy) ACCP Cardiology ... #phases #cardiology
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
patients with LV dysfunction ... rate control when beta-blockers ... conjunction with beta-blockers ... management #treatment #comparison ... #table
Pheochromocytoma - Diagnosis and Management Summary
10 percent rule = 10% of pheochromocytomas are extra-adrenal, multiple, bilateral,
Classic triad ... and other organ dysfunction ... Starting beta blockers ... • Beta blockers ... adrenoceptors, potentially leading
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
increased bleed risk Beta-Blockers ... Decreases effects of beta-blockers ... potential arrhythmias Class ... pharmacology #DDI #table ... #cardiology